WebMay 19, 2024 · Gracell Biotechnologies Inc. ("Gracell") is a global clinical-stage biopharmaceutical company dedicated to discovering and developing breakthrough cell therapies. WebGracell Biotechnologies (GRCL) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. ... Stock Ticker Symbol Market Type; Gracell Biotechnologies Inc: GRCL: NASDAQ: Depository Receipt Price Change Change Percent Stock Price Last Traded . 0.01: 0.52%: 1.95: 17:14:22: Open …
Gracell Biotechnologies to Present Clinical Data on BCMA/CD19 …
WebGracell Biotechnologies Price to Sales Ratio 2024-2024 GRCL MacroTrends Historical PS ratio values for Gracell Biotechnologies (GRCL) over the last 10 years. The current P/S ratio for Gracell Biotechnologies as of August 05, 2024 is . WebBCMA/CD19 dual-targeting FasTCAR-T GC012F data from ongoing clinical trial presented at 64 th American Society of Hematology Annual Meeting and Exposition. SAN DIEGO and SUZHOU and SHANGHAI, China, Dec. 10, 2024 /PRNewswire/ -- Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDAQ: GRCL), a global clinical-stage … fist gift wrapped
Gracell Biotechnologies - GRCL - Stock Price Today - Zacks
WebFind the latest Gracell Biotechnologies Inc. (GRCL) stock quote, history, news and other vital information to help you with your stock trading and investing. WebNov 26, 2024 · Gracell Biotechnologies Inc. (NASDAQ: NASDAQ: GRCL ), a Chinese company developing rapid cell therapy treatments for rare cancers, has created fits of both high hopes and angst among investors... WebTicker: GRCL; CUSIP Number: 38406l103; Tip: Access positions for across all investors. Analyze quarterly positions in Gracell Biotechnologies with up to 7 years of data, all … fistgear